{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:06:24Z","timestamp":1783764384585,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014471","name":"Mundipharma Research Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014471","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jfma.2020.09.011","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T09:54:22Z","timestamp":1601459662000},"page":"810-818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Increasing tramadol utilisation under strict regulatory control of opioid prescribing \u2013 A cross-sectional study in Taiwan from 2002 through 2016"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9491-0421","authenticated-orcid":false,"given":"Teng-Chou","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Peng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerina","family":"Bonar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren M.","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Arnold","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6158-6645","authenticated-orcid":false,"given":"Li-Chia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2020.09.011_bib1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.pain.2004.03.006","article-title":"Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs 2000","volume":"109","author":"Caudill-Slosberg","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.jfma.2020.09.011_bib2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.pain.2008.04.027","article-title":"Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study","volume":"138","author":"Sullivan","year":"2008","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.jfma.2020.09.011_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/AJP.0b013e318169d03b","article-title":"De facto long-term opioid therapy for noncancer pain","volume":"24","author":"Von Korff","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jfma.2020.09.011_bib4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/j.1532-2149.2014.496.x","article-title":"Changes in trends and pattern of strong opioid prescribing in primary care","volume":"18","author":"Zin","year":"2014","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jfma.2020.09.011_bib5","author":"Global Commission on Drug Policy"},{"issue":"10208","key":"10.1016\/j.jfma.2020.09.011_bib6","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global patterns of opioid use and dependence: harms to populations, interventions, and future action","volume":"394","author":"Degenhardt","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2020.09.011_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.aat.2015.05.004","article-title":"Improving access to adequate pain management in Taiwan","volume":"53","author":"Scholten","year":"2015","journal-title":"Acta Anaesthesiol Taiwan"},{"key":"10.1016\/j.jfma.2020.09.011_bib8","author":"Taiwan Food and Drug Administration"},{"key":"10.1016\/j.jfma.2020.09.011_bib9","doi-asserted-by":"crossref","first-page":"b2270","DOI":"10.1136\/bmj.b2270","article-title":"Effect of withdrawal of co-proxamol on prescribing and deaths from drug poisoning in England and Wales: time series analysis","volume":"338","author":"Hawton","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jfma.2020.09.011_bib10","first-page":"268","article-title":"Change in prescription habits after federal rescheduling of hydrocodone combination products","volume":"29","author":"Seago","year":"2016","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.jfma.2020.09.011_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamainternmed.2015.7799","article-title":"Effect of US Drug Enforcement Administration's rescheduling of hydrocodone combination analgesic products on opioid analgesic prescribing","volume":"176","author":"Jones","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jfma.2020.09.011_bib12","first-page":"1091","article-title":"Opioids for managing chronic non-malignant pain: safe and effective prescribing","volume":"52","author":"Kahan","year":"2006","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jfma.2020.09.011_bib13","author":"Advisory Council on the Misuse of Drugs"},{"key":"10.1016\/j.jfma.2020.09.011_bib14","first-page":"99","article-title":"Using Taiwan's national health insurance research databases for pharmacoepidemiology research","volume":"15","author":"Hsiao","year":"2007","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.jfma.2020.09.011_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/jjco\/hyu211","article-title":"Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review","volume":"45","author":"Chiang","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jfma.2020.09.011_bib16","author":"National Health Insurance Administration Ministry of Health and Welfare"},{"issue":"10028","key":"10.1016\/j.jfma.2020.09.011_bib17","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(16)00161-6","article-title":"Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study","volume":"387","author":"Berterame","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jfma.2020.09.011_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.aat.2016.05.002","article-title":"Key opioid prescription concerns in cancer patients: a nationwide study","volume":"54","author":"Lin","year":"2016","journal-title":"Acta Anaesthesiol Taiwan"},{"key":"10.1016\/j.jfma.2020.09.011_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jfma.2016.09.004","article-title":"Trends in major opioid analgesic consumption in Taiwan, 2002-2014","volume":"116","author":"Kang","year":"2017","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2020.09.011_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jfda.2013.05.014","article-title":"Status of management of controlled drugs in Taiwan: inspection during 2002\u20132011","volume":"21","author":"Chang","year":"2013","journal-title":"J Food Drug Anal"},{"issue":"5","key":"10.1016\/j.jfma.2020.09.011_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/pds.4320","article-title":"A 15-year overview of increasing tramadol utilisation and associated mortality and the impact of tramadol classification in the United Kingdom","volume":"27","author":"Chen","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jfma.2020.09.011_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jpainsymman.2010.01.012","article-title":"An analysis of heavy utilizers of opioids for chronic noncancer pain in the TROUP study","volume":"40","author":"Edlund","year":"2010","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.jfma.2020.09.011_bib23","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/d41586-019-02686-2","article-title":"Tracing the US opioid crisis to its roots","volume":"573","author":"DeWeerdt","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jfma.2020.09.011_bib24","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1532-5415.2009.02376.x","article-title":"Pharmacological management of persistent pain in older persons","volume":"57","author":"Ferrell","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jfma.2020.09.011_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-147-7-200710020-00008","article-title":"Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society\/American College of Physicians clinical practice guideline","volume":"147","author":"Chou","year":"2007","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.jfma.2020.09.011_bib26","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s11606-019-05150-z","article-title":"Impact of state laws restricting opioid duration on characteristics of new opioid prescriptions","volume":"34","author":"Dave","year":"2019","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jfma.2020.09.011_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF03256147","article-title":"Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences","volume":"7","author":"Wettermark","year":"2009","journal-title":"Appl Health Econ Health Pol"},{"key":"10.1016\/j.jfma.2020.09.011_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/BRS.0000000000000249","article-title":"Opioids compared with placebo or other treatments for chronic low back pain: an update of the Cochrane Review","volume":"39","author":"Chaparro","year":"2014","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.jfma.2020.09.011_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00003495-199346020-00008","article-title":"Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states","volume":"46","author":"Lee","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.jfma.2020.09.011_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.biopha.2018.12.085","article-title":"An overview of tramadol and its usage in pain management and future perspective","volume":"111","author":"Subedi","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jfma.2020.09.011_bib31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5694\/j.1326-5377.2005.tb06825.x","article-title":"Tramadol and seizures","volume":"182","author":"Boyd","year":"2005","journal-title":"Med J Aust"},{"issue":"12","key":"10.1016\/j.jfma.2020.09.011_bib32","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1592\/phco.20.19.1423.34854","article-title":"Tramadol and seizures: a surveillance study in a managed care population","volume":"20","author":"Gardner","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jfma.2020.09.011_bib33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/j.1875-9114.1998.tb03123.x","article-title":"The risk of seizures associated with tramadol","volume":"18","author":"Jick","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jfma.2020.09.011_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0897190013504957","article-title":"Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants?","volume":"27","author":"Park","year":"2014","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.jfma.2020.09.011_bib35","first-page":"17","article-title":"Tramadol: seizures, serotonin syndrome, and coadministered antidepressants","volume":"6","author":"Sansone","year":"2009","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.jfma.2020.09.011_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/pubmed\/fdn081","article-title":"Trends in drug misuse recorded in primary care in the UK from 1998 to 2005","volume":"31","author":"Frisher","year":"2009","journal-title":"J Public Health (Oxf)"},{"key":"10.1016\/j.jfma.2020.09.011_bib37","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ejpain.2010.04.006","article-title":"Classification and identification of opioid addiction in chronic pain patients","volume":"14","author":"Hojsted","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jfma.2020.09.011_bib38","first-page":"105","article-title":"Polytherapy and drug interactions in elderly","volume":"7","author":"Gujjarlamudi","year":"2016","journal-title":"J Midlife Health"},{"key":"10.1016\/j.jfma.2020.09.011_bib39","author":"World Health Organization"},{"issue":"1","key":"10.1016\/j.jfma.2020.09.011_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of Diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664620304526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664620304526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:43:55Z","timestamp":1760539435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664620304526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0929664620304526"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2020.09.011","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing tramadol utilisation under strict regulatory control of opioid prescribing \u2013 A cross-sectional study in Taiwan from 2002 through 2016","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2020.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}